EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation

Alessandro Bruno, Carmelo Gurnari, Tobias Alexander, John A Snowden, Raffaella Greco, Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation

Journal of Allergy and Clinical Immunology · 2023

DOI: 10.1016/j.jaci.2023.02.017 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023. Verfasst von Alessandro Bruno und 5 weiteren Autor:innen. Beteiligte Einrichtung: Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Hematologic Neoplasms, Hematopoietic Stem Cell Transplantation. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) is a novel entity manifesting with a multiplicity of clinical features. Somatic mutations of the UBA1 gene in hematopoietic stem cells constitute the genetic basis of VEXAS. As an X-linked disorder, most cases occur in men, classically developing symptoms during the fifth to sixth decade of life. Considering its multidisciplinary nature involving numerous branches of internal medicine, VEXAS has elicited a wide medical interest and several medical conditions have been associated with this disease. Even so, its recognition in everyday clinical practice is not necessarily straightforward. Close collaboration between different medical specialists is mandatory. Patients with VEXAS may manifest a range of features from manageable cytopenias to disabling and life-threatening autoimmune phenomena with limited responses to therapy, with the potential for progression to hematological malignancies. Diagnostic and treatment guidelines are exploratory and include a range of rheumatological and supportive care treatments. Allogeneic hematopoietic stem cell transplantation is potentially curative, but its risks are significant and its position in the treatment algorithm is yet to be defined. Herein, we present the variegated manifestations of VEXAS, provide practice criteria for diagnostic testing of UBA1, and discuss potential treatment options, including allogeneic hematopoietic stem cell transplantation, current evidence, and future directions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hematologic NeoplasmsHematopoietic Stem Cell TransplantationSkin Diseases, GeneticMaleMutationHematopoietic Stem CellsHumansMyelodysplastic SyndromesAlgorithms

Stichwörter der Autor:innen

VEXASallogeneic hematopoietic stem cell transplantautoimmune manifestationsmyelodysplastic syndrome

Autor:innen und Institutionen

  • Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.
  • Department of Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio; Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy. Electroni…
  • Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany.
  • Sheffield Blood & Marrow Transplant and Cellular Therapy Programme, Department of Haematology, Sheffield Teaching Hospitals Foundation NHS Trust, Sheffield, United Kingdom.
  • Unit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy. Electronic address: greco.raffaella@hsr.it.

Zitieren

APA

Bruno, A., Gurnari, C., Alexander, T., Snowden, J. A., Greco, R., & Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation (2023). Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. Journal of Allergy and Clinical Immunology. https://doi.org/10.1016/j.jaci.2023.02.017

Vancouver

Bruno A, Gurnari C, Alexander T, Snowden JA, Greco R, Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation. Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation. Journal of Allergy and Clinical Immunology. 2023. doi:10.1016/j.jaci.2023.02.017

BibTeX
@article{Bruno2023,
  author = {Bruno, Alessandro and Gurnari, Carmelo and Alexander, Tobias and Snowden, John A and Greco, Raffaella and Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation, Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation},
  title = {Autoimmune manifestations in VEXAS: Opportunities for integration and pitfalls to interpretation},
  journal = {Journal of Allergy and Clinical Immunology},
  year = {2023},
  doi = {10.1016/j.jaci.2023.02.017}
}
Kostenlos starten →